Strattera (Atomoxetine) and Heart Health: Cardiovascular Risks and Monitoring

Strattera, a non-stimulant ADHD medication, is generally well-tolerated but carries potential cardiovascular effects:

  • Increased heart rate: Usually mild and transient; monitor if history of heart conditions.
  • Blood pressure changes: May increase or decrease; regular monitoring advised, especially with hypertension history.
  • Rare cardiovascular events: Heart attack, stroke, arrhythmia—risk higher with pre-existing conditions or high doses.
  • QTc prolongation: Can lengthen the QT interval; rarely leads to torsades de pointes.

Overall cardiovascular risk is low, and benefits often outweigh risks. Discuss any heart concerns with your doctor before starting and during treatment.

Cardiovascular Disease - Related Articles